Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Seminars in hematology (Print)

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 9109211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells.

  1997cited by this paper
• HIV‐1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo : association with Fas‐mediated apoptosis and modulation by aurintricarboxylic acid

  1996cited by this paper
• Apoptosis--molecular mechanisms and biomedical implications.

  1996cited by this paper
• Mitochondrial control of nuclear apoptosis

  1996cited by this paper
• Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus.

  1996cited by this paper
• Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells.

  1996cited by this paper
• The pathophysiology and management of thrombotic thrombocytopenic purpura

  1996cited by this paper
• Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia.

  1996cited by this paper
• Aurin tricarboxylic acid inhibits adhesion of platelets to subendothelium.

  1996cited by this paper
• A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other

  1996cited by this paper
• Thrombotic microangiopathies associated with drugs and bone marrow transplantation.

  1996cited by this paper
• Cell cycle and apoptosis: Common pathways to life and death

  1995cited by this paper
• Apoptosis in human immunodeficiency virus-associated nephropathy.

  1995cited by this paper
• Fas ligand mediates activation-induced cell death in human T lymphocytes

  1995cited by this paper
• Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura.

  1994cited by this paper
• Haemolytic-uraemic syndrome: basic science.

  1994cited by this paper
• Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo

  1994cited by this paper
• Activation of cyclin A-dependent protein kinases during apoptosis.

  1994cited by this paper
• Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.

  1994cited by this paper
• Thrombotic microangiopathy and retroviral infections: A 13‐year experience

  1994cited by this paper
• Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells

  1993cited by this paper
• Detection of Circulating Endothelial Cells in Thrombotic Thrombocytopenic Purpura

  1993cited by this paper
• Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.

  1992cited by this paper
• Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.

  1991cited by this paper
• Novel histopathologic findings in a surviving case of hemolytic uremic syndrome after bone marrow transplantation.

  1989cited by this paper
• Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome.

  1988cited by this paper
• Pathogenesis of thrombotic thrombocytopenic purpura.

  1987cited by this paper
• Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents.

  1987cited by this paper
• Renal histopathology in the hemolytic-uremic syndrome following shigellosis.

  1984cited by this paper
• Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.

  1982cited by this paper
• Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature.

  1981cited by this paper
• The importance of nonrenal involvement in hemolytic-uremic syndrome.

  1980cited by this paper

• Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway

  2018cites this paper
• HIV infection and stroke.

  2018cites this paper
• Arterial ischemic stroke in HIV

  2016cites this paper
• Studies of ADAMTS13 expression and activity in the kidney

  2013cites this paper
• Microvascular Thrombosis: A Serious and Deadly Pathologic Process in Multiple Diseases

  2011cites this paper
• eMedicine Specialties > Emergency Medicine > Hematology & Oncology

  2009cites this paper
• Thrombotic thrombocytopenic purpura: a diagnostic and therapeutic challenge.

  2005cites this paper
• Hematologic complications of HIV infection.

  2005cites this paper
• Thrombotic Thrombocytopenic Purpura

  2005cites this paper
• Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer

  2004cites this paper
• Endothelial cell activation and apoptosis in the thrombotic microangiopathies

  2004cites this paper
• Response to Laurence

  2004cites this paper
• 36 - The cellular hematology of systemic lupus erythematosus

  2004cites this paper
• Human microvascular endothelial cells resist Shiga toxins by IFN-gamma treatment in vitro.

  2003cites this paper
• Human microvascular endothelial cells resist Shiga toxins by IFN-γ treatment in vitro

  2003cites this paper
• Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

  2003cites this paper
• Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment?

  2002cites this paper
• HIV associated thrombotic microangiopathy

  2002cites this paper
• Induction of Apoptosis of Endothelial Cells by Viscum album: A Role for Anti-Tumoral Properties of Mistletoe Lectins

  2002cites this paper
• Transplantation-associated thrombotic microangiopathy: twenty-two years later

  2002cites this paper
• Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

  2002cites this paper
• Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies.

  2002cites this paper
• Alpha-Interferon-Associated Thrombotic Microangiopathy: A Clinicopathologic Study of 8 Patients and Review of the Literature

  2002cites this paper
• Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies.

  2002cites this paper
• New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug

  2001cites this paper
• Role of transforming growth factor β1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic‐uremic syndrome

  2001cites this paper
• Thrombotic microangiopathy following renal ischaemia and revascularization: apoptosis of endothelial cells in action.

  2001cites this paper
• Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS): The New Thinking

  2001cites this paper
• Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.

  2001cites this paper
• Vascular Manifestations in Microangiopathic Syndromes

  2001cites this paper
• The Pathogenetic Role of Apoptosis in Hypercoagulable States

  2001cites this paper
• Platelet Disorders in Autoimmune Diseases

  2001cites this paper
• New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery

  2001cites this paper
• Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

  2001cites this paper
• Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.

  2001cites this paper
• Endothelial cell apoptotic genes associated with the pathogenesis of thrombotic microangiopathies: an application of oligonucleotide genechip technology.

  2001cites this paper
• Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.

  2000cites this paper
• [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].

  2000cites this paper
• Pathological and therapeutic distinctions in HUS/TTP.

  2000cites this paper
• Circulating endothelial cells and vascular injury in systemic lupus erythematosus

  2000cites this paper
• MICROANGIOPATIAS TROMBOTICAS: SUH/PTT ASPECTOS FISIOPATOLOGICOS

  2000cites this paper
• Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura in the ICU

  1999cites this paper
• Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura.

  1999cites this paper
• Thrombotic Microangiopathy Manifesting as Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome in the Cancer Patient

  1999cites this paper
• Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura.

  1999cites this paper
• Tumor necrosis factor and endothelial cell death.

  1998cites this paper
• Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells.

  1998cites this paper
• A new model of renal microvascular injury

  1998cites this paper
• Pathologic distinctions among the thrombotic microangiopathies.

  1998cites this paper
• Role of caspases 1 and 3 and Bcl‐2‐related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies

  1998cites this paper